Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $10.8450 (-6.31%) ($10.8450 - $10.8450) on Tue. Dec. 6, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.73% (three month average) | RSI | 30 | Latest Price | $10.8450(-6.31%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -2.8% a day on average for past five trading days. | Weekly Trend | BCRX declines -1.3% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) URA(24%) XLK(22%) VUG(21%) BLOK(20%) BND(19%) | Factors Impacting BCRX price | BCRX will decline at least -1.865% in a week (0% probabilities). SMH(-24%) ARKG(-14%) VIXM(-10%) SHY(-6%) TLT(-5%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.865% (StdDev 3.73%) | Hourly BBV | -1.3 () | Intraday Trend | 0% | | | |
|
Resistance Level | $12.53 | 5 Day Moving Average | $12.32(-11.97%) | 10 Day Moving Average | $12.37(-12.33%) | 20 Day Moving Average | $12.53(-13.45%) | To recent high | -23.7% | To recent low | 0% | Market Cap | $1.913b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |